1 / 44

The Great Debate: should genetic or platelet function testing be used to individualize thienopyridine regimens

Objectives. Discuss the differential advantages and disadvantages of genetic testing versus platelet function testing to predict and assess the physiologic effect of clopidogrel on plateletsList the strengths and weaknesses of clinical trials exploring the use of platelet function testing to predic

tom
Télécharger la présentation

The Great Debate: should genetic or platelet function testing be used to individualize thienopyridine regimens

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    1. J. Erin Allender, PharmD, BCPS Cardiology Critical Care Clinical Specialist WakeMed Health and Hospitals August 2010 The Great Debate: should genetic or platelet function testing be used to individualize thienopyridine regimens?

    2. Objectives Discuss the differential advantages and disadvantages of genetic testing versus platelet function testing to predict and assess the physiologic effect of clopidogrel on platelets List the strengths and weaknesses of clinical trials exploring the use of platelet function testing to predict post-procedural ischemic events and bleeding and perioperative bleeding risk Describe how the results of ongoing clinical trials may be used to individualize thienopyridine regimens

    3. Financial disclosures and conflicts of interest None I will do all of this with (unfortunately) no financial ties.I will do all of this with (unfortunately) no financial ties.

    4. Background

    5. Clopidogrel pharmacokinetics

More Related